Literature DB >> 15882202

Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection.

M I Micalessi1, L De Cock, R Vranckx.   

Abstract

Several studies have demonstrated that pathogenic and therapeutic differences exist among hepatitis B virus (HBV) genotypes. Therefore, this study established the prevalence of different HBV genotypes in 128 Belgian patients with chronic HBV infection. The prevalences of genotypes A and D, and mixed genotypes A and D, were 53%, 37% and 8%, respectively, for a group of blood donors, and 54%, 31% and 9%, respectively, for a group of patients from the gastroenterology units. The results indicated that genotypes A and D are the predominant genotypes in Belgian patients with chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882202     DOI: 10.1111/j.1469-0691.2005.01144.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay.

Authors:  Mélanie Mercier; Syria Laperche; Annie Girault; Camille Sureau; Annabelle Servant-Delmas
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

Review 2.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Common genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.

Authors:  Muhammad Masroor Alam; Sohail Zahoor Zaidi; Shehzad Shaukat; Salmaan Sharif; Mehar Angez; Asif Naeem; Shamim Saleha; Javed Aslam Butt; Salman Akbar Malik
Journal:  Virol J       Date:  2007-06-28       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.